Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report

behalf of the AREN0532 and AREN0533 study committees.

doi:10.1200/JCO.18.01972

Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report

behalf of the AREN0532 and AREN0533 study committees.

Immunology and Microbiology

Research output: Contribution to journal › Article › peer-review

45 Citations (Scopus)

Original language	English
Pages (from-to)	2769-2777
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	37
Issue number	30
DOIs	https://doi.org/10.1200/JCO.18.01972
Publication status	Published - 2019

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.18.01972

Cite this

@article{c56a8a563afa4464a35aa2734ed73183,

title = "Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report",

author = "{behalf of the AREN0532 and AREN0533 study committees.} and Dix, {David B.} and Fernandez, {Conrad V.} and Chi, {Yueh Yun} and Mullen, {Elizabeth A.} and Geller, {James I.} and Gratias, {Eric J.} and Geetika Khanna and Kalapurakal, {John A.} and Perlman, {Elizabeth J.} and Seibel, {Nita L.} and Ehrlich, {Peter F.} and Marcio Malogolowkin and James Anderson and Julie Gastier-Foster and Shamberger, {Robert C.} and Yeonil Kim and Grundy, {Paul E.} and Dome, {Jeffrey S.}",

note = "Publisher Copyright: {\textcopyright} 2019 by American Society of Clinical Oncology",

year = "2019",

doi = "10.1200/JCO.18.01972",

language = "English",

volume = "37",

pages = "2769--2777",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "30",

}

TY - JOUR

T1 - Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor

T2 - A Children's Oncology Group AREN0532 and AREN0533 study report

AU - behalf of the AREN0532 and AREN0533 study committees.

AU - Dix, David B.

AU - Fernandez, Conrad V.

AU - Chi, Yueh Yun

AU - Mullen, Elizabeth A.

AU - Geller, James I.

AU - Gratias, Eric J.

AU - Khanna, Geetika

AU - Kalapurakal, John A.

AU - Perlman, Elizabeth J.

AU - Seibel, Nita L.

AU - Ehrlich, Peter F.

AU - Malogolowkin, Marcio

AU - Anderson, James

AU - Gastier-Foster, Julie

AU - Shamberger, Robert C.

AU - Kim, Yeonil

AU - Grundy, Paul E.

AU - Dome, Jeffrey S.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85073183081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073183081&partnerID=8YFLogxK

U2 - 10.1200/JCO.18.01972

DO - 10.1200/JCO.18.01972

M3 - Article

C2 - 31449468

AN - SCOPUS:85073183081

SN - 0732-183X

VL - 37

SP - 2769

EP - 2777

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 30

ER -

Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this